Boosting the therapeutic efficiency of nanovectors: exocytosis engineering.

about

Boosting the therapeutic efficiency of nanovectors: exocytosis engineering.

Item

http://www.wikidata.org/entity/Q48163518

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Boosting the therapeutic efficiency of nanovectors: exocytosis engineering.

@en

Boosting the therapeutic efficiency of nanovectors: exocytosis engineering.

@nl

type

Item

label

Boosting the therapeutic efficiency of nanovectors: exocytosis engineering.

@en

Boosting the therapeutic efficiency of nanovectors: exocytosis engineering.

@nl

prefLabel

Boosting the therapeutic efficiency of nanovectors: exocytosis engineering.

@en

Boosting the therapeutic efficiency of nanovectors: exocytosis engineering.

@nl

P1476

Boosting the therapeutic efficiency of nanovectors: exocytosis engineering

@en

P2093

Daniela Guarnieri

http://www.w3.org/2001/XMLSchema#string

P2860

Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy

A TRP Channel Senses Lysosome Neutralization by Pathogens to Trigger Their Expulsion

Regulated lysosomal exocytosis mediates cancer progression

The third dimension bridges the gap between cell culture and live tissue

Nanocarriers as an emerging platform for cancer therapy

Drug delivery systems: entering the mainstream

Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions

Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells.

Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy.

Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.

P304

3757-3765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C7NR00364A

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pier Paolo Pompa

Stefania Corvaglia

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28261714

http://www.w3.org/2001/XMLSchema#string

P921

exocytosis